Compare Bristol-Myers Squibb Co (BMY) vs Fortinet Inc (FTNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Fortinet Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B), while Fortinet Inc trades at $160.72 (market cap $118.78B). The key difference: Bristol-Myers Squibb Co and Fortinet Inc are close in size by market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Fortinet Inc pays none. Which is the better fit depends on your goals.
| BMY | FTNT | |
|---|---|---|
Market Cap | $129.94B | $118.78B |
Sector | Health | Technology |
52-Week High | $65.89 | $168.29 |
52-Week Low | $42.60 | $75.23 |
Enterprise Value | $163.92B | $115.21B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Fortinet Inc
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →
